Behavioral Changes in Alzheimer’s Disease
Posted by Cedars on May 21, 2016
A Major problem with major change,
To date, finding ways to treat the behavioral symptoms of Alzheimer’s disease has been a challenge. But emerging research is showing progress.
Some areas Jeffrey L Cummings, MD, ScD has published,
- Calming Agitation
- Addressing Psychosis
- Overcoming Apathy
- Managing Depression
- Cognition-Enhancing Agents with Behavioral Benefit
It is important to keep in mind that a clinician’s decision to use a psychotropic agent is based on a careful consideration of the potential benefit and potential harm to the individual.
Jeffrey Cummings, MD, ScD, is Director of Cleveland Clinic Lou Ruvo Center for Brain Health and the Camille and Larry Ruvo Chair for Brain Health. Dr. Cummings’ research and leadership in the field of Alzheimer’s disease have been recognized with many awards, including the Henderson Award of the American Geriatrics Society, the Research Award of the John Douglas French Alzheimer’s Research Foundation, and the Ronald and Nancy Reagan Research Award of the national Alzheimer’s Association. In 2010 he was honored by the American Association of Geriatric Psychiatry with their Distinguished Scientist Award.
Dr. Cummings is the author of the Neuropsychiatric Inventory (NPI), the most commonly used tool for characterizing behavioral disturbances in dementia syndromes and for measuring the effect of therapies on neuropsychiatric symptoms in Alzheimer’s disease and other dementias. Dr. Cummings is an experienced clinical trialist with expertise in clinical trial design and analysis, global trial implementation, and trial outcome measures. He has published over 600 articles and 35 books on Alzheimer’s disease and related topics
Posted in : Memory Care
